Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A.
American National Red Cross, Washington, DC, United States
Search 3 grants from Todd Hembrough
Search grants from American National Red Cross
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Causes and consequences of differential mRNA localization to mRNP granules
Prostanoid Modulation of Neuronal Death
Study of fiber anatomy in mouse development by MRI/DTI
Health Administration Traineeships & Special Projects
DNA Synthesis in Mammalian Cells - Mechanism of HIV Reverse Transcriptase
Recently added grants:
Cancer Center Support Grant
Cancer Center Administration
Cancer Research Training and Education Coordina
Project 01: Cancer Biology (CB)
Project 02: Cancer Control (CC)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009910-03
Application #
6125684
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1999-12-01
Project End
Budget Start
1999-12-01
Budget End
2000-02-28
Support Year
3
Fiscal Year
2000
Total Cost
$21,616
Indirect Cost
Institution
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Related projects
NIH 2000
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
$21,616
NIH 1999
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
NIH 1998
F32 HL
Cloning and Characterization of the LR3 Receptor
Hembrough, Todd A. / American National Red Cross
Publications
Hembrough, T A; Ruiz, J F; Papathanassiu, A E et al.
(2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor.
J Biol Chem 276:12241-8
Comments
Be the first to comment on Todd Hembrough's grant